MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-11-0000464
Market Cap
₹63.63 Cr
DHANSA-ST · NSE
Share Price
₹23.65
0.00% today
Revenue
₹142 Cr
FY 2025-26
EBITDA
₹10.91 Cr
Margin 7.7%
Net Profit
₹5.50 Cr
FY 2025-26
P/E (TTM)
12.1x
P/B 0.8x
ROE
6.2%
ROCE 7.8%
Debt / Equity
0.45
Interest cover 30.2x
About Dhansa Labs Limited
Data last updated:
Dhansa Labs Limited is a public limited company based in New Delhi, Delhi, India. It operates in the crop protection segment of the agriculture sector. It was incorporated on 20 March 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN L74899DL1985PLC020490. Its GSTIN is 07AAACA4317R2ZG (Delhi). The company holds 5 GST registrations, of which 2 are active. It is a listed company as per MCA records. Its shares are listed on NSE: DHANSA.
The company has an authorised share capital of ₹37 Cr and a paid-up capital of ₹26.9 Cr. It was formerly known as Ambey Laboratories Private Limited. It is led by directors including Archit Gupta (Whole-Time Director) and Arpit Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Ground Floor Property No.555 Tarla Mohalla Ghitorni, New Delhi, Delhi, India – 110030.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹141.54 Cr. For the same year it recorded a net profit of ₹5.5 Cr (net margin 3.9%) and EBITDA of ₹10.91 Cr (EBITDA margin 7.7%). The net worth stands at ₹98.86 Cr. Total assets are valued at ₹138.94 Cr.
The company has about 88 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Ambeylab. As per MCA filings, the company has open charges of ₹138.53 Cr and satisfied charges of ₹131.52 Cr on record. Court records list 93 cases involving the company, including 34 filed by the company and 59 filed against it; 7 cases are pending. The company has 18 deals on record (10 secondary share transfers, 5 funding rounds, 2 debt financings), with disclosed funding of ₹36 Cr; the latest was in October 2024. Its 7 peer companies in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Baroda Agro Chemicals Limited with revenue of ₹145.51 Cr. The company has 3 MSME Form 1 returns on record between 2023 and 2024, listing 29 overdue payments to 11 micro and small suppliers.
Dhansa Labs Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0000464). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ambeylab.com.
Company details
CIN L74899DL1985PLC020490
Registration Number 020490
Incorporation Date 20 March 1985
ROC Delhi
Listing Status Listed (NSE: DHANSA)
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-11-0000464
Name history
Dhansa Labs has undergone 2 name changes throughout its history. The company was previously known as Ambey Laboratories Private Limited, and Dhansa Labs Limited. The current legal name is Dhansa Labs Limited.
| Company Name | Status |
|---|---|
| Dhansa Labs Limited | Current |
| Ambey Laboratories Private Limited | Previous |
CIN history
Dhansa Labs has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L74899DL1985PLC020490, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L74899DL1985PLC020490 | Current |
| U74899DL1985PLC020490 | Previous |
| U74899DL1985PTC020490 | Previous |
Recognitions & Rankings of Dhansa Labs
Contact details
Dhansa Labs Limited's registered office is in New Delhi, Delhi. Its website is ambeylab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGround Floor Property No.555 Tarla Mohalla Ghitorni, New Delhi, Delhi, India – 110030
- IndustryAgriculture, Crop Protection
To see the full contact details of Dhansa Labs Limited, buy the company report.
Comprehensive company report
Dhansa Labs Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Dhansa Labs operates one associated brand: Ambeylab. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Agrochemical intermediates and formulations are manufactured for crop protection. | ambeylab.com |
Business activity
The main business activity of Dhansa Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dhansa Labs Limited, buy the company report.
Financials of Dhansa Labs Limited
FY 2025-26 filings availableDhansa Labs Limited reported revenue of ₹141.54 Cr for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue
₹142 Cr
EBITDA
₹10.91 Cr
Profit After Tax
₹5.50 Cr
Net Worth
₹98.86 Cr
Total Assets
₹139 Cr
Total Debt
₹39.67 Cr
Financial summary ₹ Cr
| Metrics | FY 2025-26 |
|---|---|
| Income statement | |
| Revenue | 142 |
| EBITDA | 10.91 |
| EBITDA margin | +7.7% |
| Profit before tax | 7.39 |
| Net profit | 5.50 |
| Net profit margin | +3.9% |
| EPS (₹) | 2.21 |
| Balance sheet | |
| Total assets | 139 |
| Net worth | 98.86 |
| Total debt | 39.67 |
| Cash & bank | 2.50 |
| Net working capital | 89.23 |
| Cash flow | |
| Cash from operations | (4.37) |
| Cash from investing | (48.18) |
| Cash from financing | 54.02 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 30.56 | 40.54 | 32.82 |
| Other income | 0.03 | 0.88 | 0.30 |
| EBITDA | 2.64 | 2.45 | 2.57 |
| EBITDA margin | +8.6% | +6.0% | +7.8% |
| Depreciation | 0.44 | 0.54 | 0.55 |
| Interest | 0.71 | 0.38 | 0.32 |
| Profit before tax | 1.52 | 2.41 | 2.00 |
| Tax | 0.80 | 0.40 | 1.09 |
| Net profit | 0.72 | 2.01 | 0.91 |
| EPS (₹) | 0.28 | 0.80 | 0.36 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 142 | 131 | 120 | 105 | 84.60 | 81.74 |
| Revenue growth | +7.8% | +9.0% | +14.9% | +23.9% | +3.5% | - |
| EBITDA | 10.92 | 9.60 | 8.43 | 7.79 | 10.34 | 9.75 |
| EBITDA margin | +7.7% | +7.3% | +7.0% | +7.4% | +12.2% | +11.9% |
| Profit before tax | 7.60 | 6.03 | 5.43 | 5.51 | 4.82 | 3.10 |
| Net profit | 5.71 | 4.63 | 7.97 | 5.30 | 3.56 | 10.35 |
| Net profit margin | +4.0% | +3.5% | +6.6% | +5.1% | +4.2% | +12.7% |
| EPS (₹) | 2.30 | 1.92 | 4.13 | 29.52 | 20.14 | 211.23 |
| Balance sheet | ||||||
| Total assets | 139 | 118 | 61.69 | 33.26 | 38.09 | 26.03 |
| Net worth | 99.07 | 76.35 | 31.51 | 19.14 | 19.07 | (7.87) |
| Total debt | 39.57 | 40.84 | 29.64 | 14.13 | 18.04 | 32.93 |
| Cash & bank | 2.39 | 1.76 | 0.38 | 0.41 | 0.29 | 0.51 |
| Net working capital | 88.77 | 77.04 | 29.91 | 6.61 | 6.57 | 1.54 |
| Cash flow | ||||||
| Cash from operations | (1.00) | (34.48) | (13.15) | 10.05 | 5.61 | 2.74 |
| Cash from investing | (11.28) | (13.50) | (5.28) | (3.69) | (0.75) | (1.17) |
| Cash from financing | 12.92 | 48.34 | 18.39 | (6.23) | (5.08) | (1.49) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 30.56 | 40.54 | 32.82 | 39.89 | 28.29 | 30.55 | 33.07 |
| Revenue growth (YoY) | +8.0% | +32.7% | -0.8% | - | - | - | - |
| Other income | 0.63 | 1.08 | 0.30 | 0.11 | 0.02 | 0.86 | 0.28 |
| Total expenses | 27.91 | 38.21 | 30.13 | 36.86 | 25.43 | 28.20 | 31.67 |
| EBITDA | 2.65 | 2.33 | 2.69 | 3.03 | 2.86 | 2.35 | 1.40 |
| EBITDA margin | +8.7% | +5.7% | +8.2% | +7.6% | +10.1% | +7.7% | +4.2% |
| Depreciation | 0.44 | 0.54 | 0.55 | 1.37 | 0.55 | 0.67 | 0.09 |
| Interest | 0.71 | 0.38 | 0.32 | 0.10 | 1.00 | 1.00 | 0.71 |
| Profit before tax | 2.13 | 2.49 | 2.12 | 1.67 | 1.33 | 1.54 | 0.88 |
| Tax | 0.80 | 0.40 | 1.09 | 0.24 | 0.14 | 0.38 | 0.23 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 24 Oct 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|
| Revenue | 30.56 | 40.54 | 32.82 |
| Other income | 0.03 | 0.88 | 0.30 |
| EBITDA | 2.64 | 2.45 | 2.57 |
| EBITDA margin | +8.6% | +6.0% | +7.8% |
| Depreciation | 0.44 | 0.54 | 0.55 |
| Interest | 0.71 | 0.38 | 0.32 |
| Profit before tax | 1.52 | 2.41 | 2.00 |
| Tax | 0.80 | 0.40 | 1.09 |
| Net profit | 0.72 | 2.01 | 0.91 |
| EPS (₹) | 0.28 | 0.80 | 0.36 |
| Particulars | FY 2025-26 |
|---|---|
| Revenue | 142 |
| Other income | 1.31 |
| Total expenses | 131 |
| Employee cost | 1.02 |
| EBITDA | 10.91 |
| EBITDA margin | +7.7% |
| Depreciation | 2.20 |
| Interest | 2.63 |
| Profit before tax | 7.39 |
| Tax | 1.87 |
| Net profit | 5.50 |
| Net profit margin | +3.9% |
| EPS (₹) | 2.21 |
| Particulars | FY 2025-26 |
|---|---|
| Equity & liabilities | |
| Share capital | 24.95 |
| Reserves & surplus | 56.93 |
| Shareholders' funds (net worth) | 98.86 |
| Minority interest | 0.00 |
| Secured loans | 39.57 |
| Unsecured loans | 0.10 |
| Total debt | 39.67 |
| Total liabilities | 139 |
| Assets | |
| Gross block | 61.56 |
| Net block | 24.32 |
| Capital work in progress | 22.78 |
| Investments | 0.00 |
| Inventories | 31.54 |
| Sundry debtors | 53.90 |
| Cash & bank balances | 2.50 |
| Loans & advances | 13.27 |
| Total current assets | 101 |
| Total current liabilities | 11.98 |
| Net working capital | 89.23 |
| Total assets | 139 |
| Particulars | FY 2025-26 |
|---|---|
| Opening cash | 0.00 |
| Net cash from operating activities | (4.37) |
| Net cash from investing activities | (48.18) |
| Net cash from financing activities | 54.02 |
| Net change in cash | 1.48 |
| Closing cash | 2.50 |
| Particulars | FY 2025-26 |
|---|---|
| Growth | |
| PBT growth | +9997.0% |
| Profitability & leverage | |
| Net income margin | +3.9% |
| Return on capital employed | +7.8% |
| Return on net worth | +6.3% |
| Debt / equity | 0.45 |
| Long-term debt / equity | 0.21 |
| Interest cover | 30.20 |
| Efficiency & per share | |
| Fixed asset turnover | 2.77 |
| Inventory turnover | 4.49 |
| Debtors turnover | 2.63 |
| EPS (₹) | 2.21 |
| Dividend per share (₹) | 0.00 |
| Book value per share (₹) | 28.61 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 30.56 | 40.54 | 32.82 | 39.89 | 28.29 | 30.55 | 33.07 |
| Revenue growth (YoY) | +8.0% | +32.7% | -0.8% | - | - | - | - |
| Other income | 0.63 | 1.08 | 0.30 | 0.11 | 0.02 | 0.86 | 0.28 |
| Total expenses | 27.91 | 38.21 | 30.13 | 36.86 | 25.43 | 28.20 | 31.67 |
| EBITDA | 2.65 | 2.33 | 2.69 | 3.03 | 2.86 | 2.35 | 1.40 |
| EBITDA margin | +8.7% | +5.7% | +8.2% | +7.6% | +10.1% | +7.7% | +4.2% |
| Depreciation | 0.44 | 0.54 | 0.55 | 1.37 | 0.55 | 0.67 | 0.09 |
| Interest | 0.71 | 0.38 | 0.32 | 0.10 | 1.00 | 1.00 | 0.71 |
| Profit before tax | 2.13 | 2.49 | 2.12 | 1.67 | 1.33 | 1.54 | 0.88 |
| Tax | 0.80 | 0.40 | 1.09 | 0.24 | 0.14 | 0.38 | 0.23 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 142 | 131 | 120 | 105 | 84.60 | 81.74 |
| Revenue growth | +7.8% | +9.0% | +14.9% | +23.9% | +3.5% | - |
| Other income | 1.51 | 1.92 | 1.59 | 2.77 | 0.51 | 0.68 |
| Total expenses | 131 | 122 | 112 | 97.03 | 74.26 | 71.99 |
| Employee cost | 1.02 | 1.36 | 1.38 | 2.21 | 1.70 | 1.68 |
| EBITDA | 10.92 | 9.60 | 8.43 | 7.79 | 10.34 | 9.75 |
| EBITDA margin | +7.7% | +7.3% | +7.0% | +7.4% | +12.2% | +11.9% |
| Depreciation | 2.20 | 2.54 | 2.17 | 2.96 | 2.97 | 3.22 |
| Interest | 2.63 | 2.95 | 2.42 | 2.09 | 3.06 | 4.11 |
| Profit before tax | 7.60 | 6.03 | 5.43 | 5.51 | 4.82 | 3.10 |
| Tax | 1.87 | 1.26 | (2.29) | 0.26 | 1.26 | (7.25) |
| Net profit | 5.71 | 4.63 | 7.97 | 5.30 | 3.56 | 10.35 |
| Net profit margin | +4.0% | +3.5% | +6.6% | +5.1% | +4.2% | +12.7% |
| EPS (₹) | 2.30 | 1.92 | 4.13 | 29.52 | 20.14 | 211.23 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 24.95 | 24.95 | 18.69 | 17.75 | 17.75 | 4.89 |
| Reserves & surplus | 57.14 | 51.40 | 12.82 | 1.39 | 1.32 | (12.76) |
| Shareholders' funds (net worth) | 99.07 | 76.35 | 31.51 | 19.14 | 19.07 | (7.87) |
| Secured loans | 39.57 | 40.84 | 28.91 | 11.36 | 14.13 | 16.34 |
| Unsecured loans | 0.00 | 0.00 | 0.73 | 2.77 | 3.91 | 16.59 |
| Total debt | 39.57 | 40.84 | 29.64 | 14.13 | 18.04 | 32.93 |
| Total liabilities | 139 | 118 | 61.69 | 33.26 | 38.09 | 26.03 |
| Assets | ||||||
| Gross block | 58.23 | 58.35 | 57.10 | 56.17 | 53.08 | 40.87 |
| Net block | 20.99 | 23.11 | 23.97 | 25.21 | 25.09 | 15.85 |
| Capital work in progress | 22.04 | 15.66 | 3.84 | 0.00 | 0.00 | 0.95 |
| Investments | 0.10 | 0.00 | 0.78 | 0.60 | 0.00 | 0.00 |
| Inventories | 31.54 | 29.91 | 20.57 | 17.12 | 10.75 | 8.73 |
| Sundry debtors | 53.90 | 40.43 | 18.69 | 3.57 | 8.52 | 6.97 |
| Cash & bank balances | 2.39 | 1.76 | 0.38 | 0.41 | 0.29 | 0.51 |
| Loans & advances | 11.19 | 14.42 | 7.99 | 6.22 | 4.85 | 3.92 |
| Total current assets | 99.02 | 86.52 | 47.63 | 27.32 | 24.41 | 20.13 |
| Total current liabilities | 10.25 | 9.48 | 17.72 | 20.71 | 17.84 | 18.59 |
| Net working capital | 88.77 | 77.04 | 29.91 | 6.61 | 6.57 | 1.54 |
| Total assets | 139 | 118 | 61.69 | 33.26 | 38.09 | 26.03 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 0.73 | 0.37 | 0.40 | 0.27 | 0.51 | 0.43 |
| Net cash from operating activities | (1.00) | (34.48) | (13.15) | 10.05 | 5.61 | 2.74 |
| Net cash from investing activities | (11.28) | (13.50) | (5.28) | (3.69) | (0.75) | (1.17) |
| Net cash from financing activities | 12.92 | 48.34 | 18.39 | (6.23) | (5.08) | (1.49) |
| Net change in cash | 0.64 | 0.36 | (0.03) | 0.13 | (0.22) | 0.09 |
| Closing cash | 2.39 | 1.76 | 0.38 | 0.41 | 0.29 | 0.51 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +7.8% | +9.0% | +14.9% | +23.9% | +3.5% | - |
| EBITDA growth | +13.8% | +13.9% | +8.2% | -24.7% | +6.1% | - |
| PBT growth | +26.0% | +11.1% | -1.5% | +14.3% | +55.5% | +9997.0% |
| Net income growth | +23.3% | -41.9% | +50.4% | +48.9% | -65.6% | - |
| Revenue CAGR (3Y) | +10.5% | +15.8% | +13.8% | - | - | - |
| EBITDA CAGR (3Y) | +11.9% | -2.4% | -4.7% | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +4.1% | +3.6% | +6.4% | +5.0% | +4.2% | +12.7% |
| Return on capital employed | +8.7% | +11.3% | +18.6% | +22.1% | +20.9% | +18.6% |
| Return on net worth | +7.4% | +10.8% | +38.5% | +29.5% | +31.5% | +211.5% |
| Debt / equity | 0.52 | 0.81 | 1.48 | 1.87 | 72.82 | 0.00 |
| Long-term debt / equity | 0.19 | 0.31 | 1.00 | 1.54 | 60.10 | 0.00 |
| Interest cover | 30.16 | 41.78 | 38.66 | 43.27 | 41.52 | 62.94 |
| Efficiency & per share | ||||||
| Fixed asset turnover | 2.96 | 2.78 | 2.61 | 2.38 | 2.03 | 2.00 |
| Inventory turnover | 4.61 | 5.20 | 6.39 | 7.52 | 8.69 | 9.36 |
| Debtors turnover | 3.00 | 4.44 | 10.82 | 17.34 | 10.92 | 11.73 |
| EPS (₹) | 2.30 | 1.92 | 4.13 | 29.52 | 20.14 | 211.23 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 28.69 | 26.40 | 11.24 | 48.69 | 48.26 | (160.70) |
To see the full year-wise statements and ratios of Dhansa Labs Limited, buy the company report.
Board of directors of Dhansa Labs Limited
Dhansa Labs has 5 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archit Gupta Also directs: Dhansa Green Energy Private Limited, Dhansa Renewable Fuels Private Limited, Dhansa Biofuels Power Private Limited and 1 more | Whole-Time Director | 02 Sep 2025 | 1 Years 1 Months | Current |
| Arpit Gupta Also directs: Dhansa Green Energy Private Limited, Dhansa Renewable Fuels Private Limited, Dhansa Biofuels Power Private Limited and 1 more | Director | 02 Sep 2025 | 1 Years 1 Months | Current |
| Abdul Quadir | Director | 30 Sep 2023 | 3 Years 0 Months | Current |
| Bharti Kashyap | Director | 02 Sep 2025 | 1 Years 1 Months | Current |
| Roni Soni Also directs: Frost Falcon Distilleries Limited, Ais Consumer Glass Solutions Limited, Kanodia Technoplast Limited and 1 more | Director | 20 Jul 2023 | 3 Years 3 Months | Current |
Peer comparison
Dhansa Labs Limited is compared with the 7 companies closest to it by revenue in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Baroda Agro Chemicals Limited | ₹145.51 Cr (FY 2025) | 3.0% | Raluka Halol Panchmahals, Gujarat, India | |||
| Dhansa Labs Limitedthis company | ₹141.54 Cr (FY 2026) | ₹5.5 Cr | 3.9% | 88 | New Delhi, Delhi, India | |
| Ajinkya Chemtech Private Limited | ₹140.7 Cr (FY 2025) | 18.0% | Pune, Maharashtra, India | |||
| Nova Agri Sciences Private Limited | ₹140.49 Cr (FY 2025) | 26.0% | Siddipet, Telangana, India | |||
| Synergia Sciences Private Limited | ₹134.56 Cr (FY 2025) | 53.0% | Mumbai, Maharashtra, India | |||
| Prism Crop Science Limited | ₹131.78 Cr (FY 2024) | 1.0% | Hyderabad, Telangana, India | |||
| Prathibha Biotech Private Limited | ₹130.44 Cr (FY 2025) | 5.0% | Hyderabad, Telangana, India | |||
| Isagro (Asia) Agrochemicals Private Limited | ₹130.4 Cr (FY 2021) | -53.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Dhansa Labs Limited, buy the company report.
Auditor
Dhansa Labs Limited is audited by SASTRY K. ANANDAM & CO. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SASTRY K. ANANDAM & CO. LLP | FY 2023 | 000179N/N500051 |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 65.00%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 35.00%.
Sep 2026
QUARTER
65.00% Promoters
35.00% Retail & Others
Promoter holding - history
Now 65.00% · Sep 2026High 70.20% · Mar 2026Low 65.00% · Sep 2026
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 65.00% | 70.20% | 70.20% | 70.10% |
| Public | 35.00% | 29.80% | 29.80% | 29.90% |
Charges & borrowings
Open charges
₹138.53 Cr
Satisfied charges
₹131.52 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Aug 2026 | 101376137 | Others | ₹84.82 Cr | Open | |
| 31 Jul 2026 | 101369053 | Others | ₹1.4 Cr | Open | |
| 31 Jul 2026 | 101371132 | Others | ₹1.4 Cr | Open | |
| 31 Jul 2026 | 101371137 | Others | ₹1.4 Cr | Open | |
| 31 Jul 2026 | 101371141 | Others | ₹1.4 Cr | Open |
To see the full charge records of Dhansa Labs Limited, buy the company report.
Total charge records: 35 View all charges
Deals & funding
Dhansa Labs Limited has 18 deals on record (10 secondary share transfers, 5 funding rounds, 2 debt financings), with disclosed funding of ₹36 Cr; the latest was in October 2024.
Total deals
18
Secondary share transfers
10
Funding rounds
5
Debt financings
2
IPO
1
Disclosed funding
₹36 Cr
Deals on record (5 of 18)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: Nikunj Stock Brokers Limited , Divine Comex Enterprises Private Limited , an individual Seller: Unlisted Assets Private Limted |
| Oct 2023 | Funding round | ₹4.65 Cr | Investors: Unlisted Assets Private Limted, Oregano Life Private Limited , 2 individuals |
| Aug 2018 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Ambey Capital Private Limited |
| Dec 2012 | Secondary share transfer | Undisclosed | Buyer: Ambey Capital Private Limited Seller: 4 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Ambey Laboratories Limited |
To see the full deal history of Dhansa Labs Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Dhansa Labs Limited has 93 court cases on record: 34 filed by Dhansa Labs, 59 filed against it. 7 cases are pending and 86 are disposed.
Total cases
93
Filed by the company
34
Filed against the company
59
Pending
7
Disposed
86
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 61 | 56 | 2 |
| High courts | 30 | 2 | 5 |
| Supreme Court | 1 | 0 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 93)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Appeal | Filed against the company by M/S Revex Polymers Pvt. Ltd. (Now M/S Revex Plasticisers Pvt. Ltd.) and 1 other | Pending |
| Bombay High Court | Writ petition | Filed by the company against Reserve Bank of India Thru. Its Governor, | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Reserve Bank of India Thru. Its Governor, and 2 others | Disposed |
| District court, West, Delhi | Execution petition | Filed against the company by M/S Sun Chem Process Machines Pvt. Ltd. Through Its Director Mr. Ravinder Singh Chauhan | Disposed |
| District court, West, Delhi | Interim or miscellaneous application | Filed against the company by Sun Chem Process Machines Pvt. Ltd. | Disposed |
To see the full case history of Dhansa Labs Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Dhansa Labs Limited has 3 MSME Form 1 returns on record between 2023 and 2024, listing 29 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Delta Packaging | |||
| an individual supplier | |||
| an individual supplier | |||
| Galaxy Print Services Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Dhansa Labs Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Dhansa Labs Limited has a workforce of 88 employees on its EPFO records as of Apr 03, 2024, across 1 active EPFO establishment.
Employee count
88
Active EPFO establishments
1
Employee growth
4.76%
GST
Dhansa Labs has 5 GST registrations: 2 active and 3 cancelled or inactive.
Total GSTINs
5
Active
2
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACA4317R2ZG | Delhi | Active | 27 Mar 2024 |
| 08AAACA4317R1ZF | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dhansa Labs Limited, buy the company report.
Recent activity
Dhansa Labs Limited has 17 board changes on record since 2012: 5 appointments and 12 cessations. The latest: Bharti Kashyap ceased to be Additional Director on 29 Sep 2025.
Charges
A charge with Others of Rs. 8.00 Cr registered on 28 Jun 2025 with Charge ID 101122522 was modified on 24 Aug 2026.
Charges
A charge with Yes Bank Limited of Rs. 26.57 Cr registered on 13 Sep 2024 with Charge ID 100981977 was modified on 24 Aug 2026.
Charges
A charge with Others amounted to Rs. 84.82 Cr with Charge ID 101376137 was registered on 14 Aug 2026.
Charges
A charge with Others amounted to Rs. 1.40 Cr with Charge ID 101369053 was registered on 31 Jul 2026.
Charges
A charge with Others amounted to Rs. 1.40 Cr with Charge ID 101371132 was registered on 31 Jul 2026.
Charges
A charge with Others amounted to Rs. 1.40 Cr with Charge ID 101371137 was registered on 31 Jul 2026.
Charges
A charge with Others amounted to Rs. 1.40 Cr with Charge ID 101371141 was registered on 31 Jul 2026.
Charges
A charge with Others amounted to Rs. 1.40 Cr with Charge ID 101373603 was registered on 31 Jul 2026.
Filing
Dhansa Labs Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi I.
Charges
A charge with Others amounted to Rs. 2.75 Cr with Charge ID 101304650 was registered on 28 Feb 2026.
AGM
Dhansa Labs Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Bharti Kashyap ceased to be Additional Director.
81 earlier events are in the company report.
Frequently asked questions
Dhansa Labs is an active public limited company based in New Delhi, Delhi, India. The company works in crop protection, within the agriculture industry. It was incorporated on 20 March 1985 (41+ years old) and is registered under CIN L74899DL1985PLC020490. Listed on NSE: DHANSA.
Dhansa Labs reported revenue of ₹141.54 Cr for FY 2025-26 based on consolidated financials.
Dhansa Labs has 5 current directors:
- Archit Gupta - Whole-Time Director
- Arpit Gupta - Director
- Abdul Quadir - Director
- Bharti Kashyap - Director
- Roni Soni - Director
The latest financial statements of Dhansa Labs on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dhansa Labs is 07AAACA4317R2ZG, registered in Delhi. The company has 5 GST registrations in all, of which 2 are active and 3 are cancelled or inactive. Other active GSTINs include 08AAACA4317R1ZF (Rajasthan).
The CIN (Corporate Identification Number) of Dhansa Labs is L74899DL1985PLC020490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Dhansa Labs is a listed company as per MCA records. Its shares are listed on NSE (symbol: DHANSA).
Dhansa Labs has 93 court cases on record: 34 filed by the company and 59 filed against it. 7 are pending. Most are in the district courts.
Dhansa Labs was incorporated on 20 March 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.
Dhansa Labs has 18 deals on record (10 secondary share transfers, 5 funding rounds, 2 debt financings), with disclosed funding of ₹36 Cr; the latest was in October 2024.
The peers of Dhansa Labs by revenue are Baroda Agro Chemicals Limited, Ajinkya Chemtech Private Limited, Nova Agri Sciences Private Limited, Synergia Sciences Private Limited, Prism Crop Science Limited and 2 more, all in the Agriculture industry (Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bharti Kashyap ceased to be Additional Director on 29 Sep 2025. Archit Gupta was appointed as Whole-Time Director on 02 Sep 2025. Arpit Gupta was appointed as Director on 02 Sep 2025. Dhansa Labs has 17 board changes on record in total.